[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346055-105":59,"doc-detail-346055-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","shifting-cancer-landscapes-in-korea-divergent-incidence-trajectories-sex-specific-burdens-and-projected-case-counts","Shifting Cancer Landscapes in Korea - Divergent Incidence Trajectories, Sex-Specific Burdens, and Projected Case Counts","","Examines how Korea’s cancer epidemiology has changed from 1999 to 2023 across 24 major cancer types, using nationwide cancer registry data to map age-standardized incidence rate (ASIR) trajectories, quantify sex-specific burdens, and forecast future case counts. Annual incidence data by sex, ASIRs per 100,000 (2020 Korean standard population), and age trends are analyzed with log-linear regression for annual percent change and Holt–Winters damped exponential smoothing for 2024–2030 projections. Total incidence rose from 101,854 to 288,613 cases, with divergent cancer-type trends and a substantially higher female ASIR increase (+65.9% vs +2.4% in males).",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/shifting-cancer-landscapes-in-korea-divergent-incidence-trajectories-sex-specific-burdens-and-projected-case-counts/346055/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/shifting-cancer-landscapes-in-korea-divergent-incidence-trajectories-sex-specific-burdens-and-projected-case-counts/346055.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What data and study period are used to characterize Korea’s cancer incidence trends?","Question",{"text":112,"@type":113},"The study uses 25 years of nationwide cancer registry data from the Korea Central Cancer Registry for 24 major cancer types, covering 1999–2023.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which cancer types showed the fastest increases and the largest declines?",{"text":117,"@type":113},"Thyroid (+7.56%/year), prostate (+6.98%), testis (+5.39%), breast (+5.03%), and corpus uteri (+5.03%) increased most, while cervix uteri (−3.81%), larynx (−3.18%), liver (−2.90%), and stomach (−2.20%) declined significantly.",{"name":119,"@type":110,"acceptedAnswer":120},"How were future case counts projected through 2030?",{"text":121,"@type":113},"The projections used Holt–Winters damped exponential smoothing to generate 2024–2030 estimates with 95% prediction intervals, while interpreting changes alongside improvements in ascertainment and coding.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346055,1790188771,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","Article  \nShifting Cancer Landscapes in Korea: Divergent Incidence  \nTrajectories, Sex-Specific Burdens, and Projected Case Counts for 24 Major Cancer Types from 1999 to 2023, with Forecasts to 2030 Hyeran Jung and Minsun Jung *  \nReceived: 23 June 2026  \nRevised: 14 July 2026  \nAccepted: 23 July 2026  \nPublished: 24 July 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \nDepartment of Pathology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea; phdgrace@yuhs.ac  \n* [Correspondence: jjunglammy@yuhs.ac](Correspondence: jjunglammy@yuhs.ac)  \nSimple Summary  \nKorea has undergone a fundamental restructuring of its cancer burden over the past quartercentury. Using 25 years of nationwide cancer registry data from the Korea Central Cancer Registry (KCCR) for the 24 major cancer types defined in national reporting (1999–2023), this study characterizes divergent age-standardized incidence rate (ASIR) trajectories, quantifies sex-specific burdens, and projects case counts through 2030 using Holt–Winters exponential smoothing. The fastest-growing cancer types by annual percent change (APC) were thyroid (+7.56%/year), prostate (+6.98%), testis (+5.39%), breast (+5.03%), and corpus uteri (+5.03%) . Conversely, cervix uteri (−3.81%), larynx (−3.18%), liver (−2.90%), and stomach (−2.20%) cancers declined significantly. Female ASIR rose by 65.9%, far exceeding the 2.4% increase in male ASIR, driven predominantly by thyroid, breast, and corpus uteri cancers. Total cancer incidence is projected to reach approximately 330,000 cases by 2030 . Because case ascertainment and diagnostic practices have also improved over the study period, part of the apparent increase reflects changes in detection and registration; these cancer-type-resolved findings nonetheless provide a quantitative foundation for national cancer control planning in Korea.  \nAbstract  \nBackground/Objectives: Korea has experienced rapid and heterogeneous shifts in cancer epidemiology since 1999 . We aimed to characterize divergent incidence trajectories across the 24 major cancer types, quantify sex-specific burdens, and project case counts through 2030. Methods: Annual incidence data—including new case counts and age-standardized incidence rates (ASIRs) per 100,000 (2020 Korean standard population) stratified by sex—were extracted from the KCCR via the Korean Statistical Information Service (KOSIS) for 1999–2023. Annual percent change (APC) was estimated by log-linear regression with 95% confidence intervals (CIs) . Holt–Winters damped exponential smoothing generated 2024–2030 projections with 95% prediction intervals (PIs) . Changes in case ascertainment and coding over the study period were considered in interpretation. Results: Total incidence increased from 101,854 (1999) to 288,613 cases (2023), a 183.4% increase. Overall ASIR rose from 402.7 to 522.9 per 100,000 . Of the 24 cancer types, 15 showed statistically significant increasing ASIR trends, 6 showed significant decreasing trends, and 3 showed no significant change. The highest-APC cancers were thyroid (+7.56%), prostate (+6.98%), testis (+5.39%), breast (+5.03%), and corpus uteri (+5.03%; all p \u003C 0.001) . The largest significant declines occurred in cervix uteri (−3.81%), larynx (−3.18%), liver (−2.90%), and stomach (−2.20%; all p \u003C 0.001) . Female ASIR increased from 294.7 to 488.9 per 100,000 (+65.9%); male ASIR increased from 573.3 to 587.0 per 100,000 (+2.4%) . Total cancer incidence is projected to  \nreach 307,091 (95% PI: 281,200–332,983) in 2026 and 330,213 (95% PI: 290,663–369,763) by 2030, with the steepest projected relative growth for prostate (+48.9%), kidney (+33.7%), and breast (+31.3%) cancers. Conclusions: Korean cancer epidemiology is undergoing a pronounced transition from infection-related toward metabolic, hormonal, and ","cbCailqK2E1mDZ5v","https://ap.wps.com/l/cbCailqK2E1mDZ5v","pdf",6607102,14,"English","# Introduction\n## Methods and data sources\n## Results and projected case counts\n## Conclusions\n# Keywords","[{\"question\":\"What data and study period are used to characterize Korea’s cancer incidence trends?\",\"answer\":\"The study uses 25 years of nationwide cancer registry data from the Korea Central Cancer Registry for 24 major cancer types, covering 1999–2023.\"},{\"question\":\"Which cancer types showed the fastest increases and the largest declines?\",\"answer\":\"Thyroid (+7.56%/year), prostate (+6.98%), testis (+5.39%), breast (+5.03%), and corpus uteri (+5.03%) increased most, while cervix uteri (−3.81%), larynx (−3.18%), liver (−2.90%), and stomach (−2.20%) declined significantly.\"},{\"question\":\"How were future case counts projected through 2030?\",\"answer\":\"The projections used Holt–Winters damped exponential smoothing to generate 2024–2030 estimates with 95% prediction intervals, while interpreting changes alongside improvements in ascertainment and coding.\"}]","Shifting Cancer Landscapes in Korea - Divergent Incidence Trajectories, Sex-Specific Burdens, and Projected Case Counts | PDF",1790059880,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a4edc5670562ba2859af40f9646dce0.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b11c3e77834ffc9c6e759c08447b3bc3.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fad11345b79438ecc745ba0e2ae0990b.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64e9a831de46d881e0c2d1d0af2b98e3.webp",980,1385]